Pharmaceutical Business review

Medidata Solutions Q1 revenues surge

The company has reported a net income of $3.19m, or $0.13 loss per diluted share, compared to net income of $1.86m or $0.08 per diluted share, for the same period last year.

Medidata Solutions’ operating income was $3.47m, as compared to $2.94m for the same period prior year.

Gross profit was $27.67m, as compared to $25.07m for the same period in 2010.

Medidata Solutions chief financial officer and executive vice president Bruce Dalziel said they have established a steady and consistent track record of gross margin expansion, high renewal rates and overall profitable growth.

"As reflected in our first quarter results, 2011 is expected to be a good year in terms of profitability and operating cash flow growth," Dalziel said.